APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory and Antipyretic Granules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Anti-inflammatory and Antipyretic Granules Market Analysis and Forecast 2026-2032

27 December 2025204 pages

Choose your research edition.

Industry ResearchAnti-inflammatory and Antipyretic Granules Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory and Antipyretic Granules Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory and Antipyretic Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory and Antipyretic Granules Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory and Antipyretic Granules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Anti-inflammatory and Antipyretic Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Anti-inflammatory and Antipyretic Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Anti-inflammatory and Antipyretic Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Anti-inflammatory and Antipyretic Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Anti-inflammatory and Antipyretic Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Anti-inflammatory and Antipyretic Granules include Dong'e Ejiao Co., Ltd., Guangdong Baihe Pharmaceutical Co., Ltd., Guangxi Tiantianle Pharmaceutical Co., Ltd., Hebei Tiancheng Pharmaceutical Co., Ltd., Hubei Dongxin Pharmaceutical Co., Ltd., Hubei Nordeson Pharmaceutical Co., Ltd., Jilin Xianfeng Technology Pharmaceutical Co., Ltd., Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. and Liaoning Xingao Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Anti-inflammatory and Antipyretic Granules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Anti-inflammatory and Antipyretic Granules, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-inflammatory and Antipyretic Granules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-inflammatory and Antipyretic Granules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Anti-inflammatory and Antipyretic Granules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Anti-inflammatory and Antipyretic Granules sales, projected growth trends, production technology, application and end-user industry.

Anti-inflammatory and Antipyretic Granules Segment by Company

Dong'e Ejiao Co., Ltd.

Guangdong Baihe Pharmaceutical Co., Ltd.

Guangxi Tiantianle Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hubei Dongxin Pharmaceutical Co., Ltd.

Hubei Nordeson Pharmaceutical Co., Ltd.

Jilin Xianfeng Technology Pharmaceutical Co., Ltd.

Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.

Liaoning Xingao Pharmaceutical Co., Ltd.

Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.

Shaanxi Buchang Pharmaceutical Co., Ltd.

Shaanxi Han Tang Pharmaceutical Co., Ltd.

Shenyang Junyuan Pharmaceutical Co., Ltd.

Sichuan Kelun Pharmaceutical Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

Yunnan Longfa Pharmaceutical Co., Ltd.

Anti-inflammatory and Antipyretic Granules Segment by Type

Pack of 10

Pack of 16

Anti-inflammatory and Antipyretic Granules Segment by Application

Online Sales

Offline Sales

Anti-inflammatory and Antipyretic Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory and Antipyretic Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory and Antipyretic Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory and Antipyretic Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Anti-inflammatory and Antipyretic Granules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Anti-inflammatory and Antipyretic Granules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-inflammatory and Antipyretic Granules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Anti-inflammatory and Antipyretic Granules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pack of 10 Major Manufacturers Table 3. Pack of 16 Major Manufacturers Table 4. Global Anti-inflammatory and Antipyretic Granules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Online Sales Major Manufacturers Table 6. Offline Sales Major Manufacturers Table 7. Anti-inflammatory and Antipyretic Granules Industry Trends Table 8. Anti-inflammatory and Antipyretic Granules Industry Drivers Table 9. Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges Table 10. Anti-inflammatory and Antipyretic Granules Industry Restraints Table 11. Global Anti-inflammatory and Antipyretic Granules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021-2026) Table 15. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2027-2032) Table 16. Global Anti-inflammatory and Antipyretic Granules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026) & (K Units) Table 18. Global Anti-inflammatory and Antipyretic Granules Sales by Region (2027-2032) & (K Units) Table 19. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021-2026) Table 20. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2027-2032) Table 21. Global Anti-inflammatory and Antipyretic Granules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Anti-inflammatory and Antipyretic Granules Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Manufacturers (2021-2026) Table 25. Global Anti-inflammatory and Antipyretic Granules Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Anti-inflammatory and Antipyretic Granules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Anti-inflammatory and Antipyretic Granules Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Anti-inflammatory and Antipyretic Granules Manufacturers, Product Type & Application Table 29. Global Anti-inflammatory and Antipyretic Granules Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Anti-inflammatory and Antipyretic Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Anti-inflammatory and Antipyretic Granules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2026) Table 36. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2027-2032) Table 37. Global Anti-inflammatory and Antipyretic Granules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 39. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 40. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2026) Table 41. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2027-2032) Table 42. Global Anti-inflammatory and Antipyretic Granules Price by Type (2021-2026) & (US$/Unit) Table 43. Global Anti-inflammatory and Antipyretic Granules Price by Type (2027-2032) & (US$/Unit) Table 44. Global Anti-inflammatory and Antipyretic Granules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2026) Table 48. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2027-2032) Table 49. Global Anti-inflammatory and Antipyretic Granules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 51. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 52. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2026) Table 53. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2027-2032) Table 54. Global Anti-inflammatory and Antipyretic Granules Price by Application (2021-2026) & (US$/Unit) Table 55. Global Anti-inflammatory and Antipyretic Granules Price by Application (2027-2032) & (US$/Unit) Table 56. Dong'e Ejiao Co., Ltd. Company Information Table 57. Dong'e Ejiao Co., Ltd. Business Overview Table 58. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 60. Dong'e Ejiao Co., Ltd. Recent Development Table 61. Guangdong Baihe Pharmaceutical Co., Ltd. Company Information Table 62. Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview Table 63. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 65. Guangdong Baihe Pharmaceutical Co., Ltd. Recent Development Table 66. Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information Table 67. Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview Table 68. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 70. Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Development Table 71. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 72. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 73. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 75. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Development Table 76. Hubei Dongxin Pharmaceutical Co., Ltd. Company Information Table 77. Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview Table 78. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 80. Hubei Dongxin Pharmaceutical Co., Ltd. Recent Development Table 81. Hubei Nordeson Pharmaceutical Co., Ltd. Company Information Table 82. Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview Table 83. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 85. Hubei Nordeson Pharmaceutical Co., Ltd. Recent Development Table 86. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information Table 87. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview Table 88. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 90. Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Development Table 91. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information Table 92. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview Table 93. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 95. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Development Table 96. Liaoning Xingao Pharmaceutical Co., Ltd. Company Information Table 97. Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview Table 98. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 100. Liaoning Xingao Pharmaceutical Co., Ltd. Recent Development Table 101. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information Table 102. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview Table 103. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 105. Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Development Table 106. Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information Table 107. Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview Table 108. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 110. Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Development Table 111. Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information Table 112. Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview Table 113. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 115. Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Development Table 116. Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information Table 117. Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview Table 118. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 120. Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Development Table 121. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information Table 122. Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview Table 123. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 125. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Development Table 126. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 127. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 128. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 130. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 131. Yunnan Baiyao Group Co., Ltd. Company Information Table 132. Yunnan Baiyao Group Co., Ltd. Business Overview Table 133. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 135. Yunnan Baiyao Group Co., Ltd. Recent Development Table 136. Yunnan Longfa Pharmaceutical Co., Ltd. Company Information Table 137. Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview Table 138. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio Table 140. Yunnan Longfa Pharmaceutical Co., Ltd. Recent Development Table 141. North America Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 142. North America Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 143. North America Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 144. North America Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 145. North America Anti-inflammatory and Antipyretic Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 146. North America Anti-inflammatory and Antipyretic Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 147. North America Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 148. North America Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 149. North America Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 150. North America Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 151. North America Anti-inflammatory and Antipyretic Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 152. North America Anti-inflammatory and Antipyretic Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 153. North America Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. North America Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. North America Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 157. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 158. North America Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 159. North America Anti-inflammatory and Antipyretic Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 160. North America Anti-inflammatory and Antipyretic Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 161. United States Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 162. Canada Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 163. Mexico Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 164. Europe Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 167. Europe Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 168. Europe Anti-inflammatory and Antipyretic Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Europe Anti-inflammatory and Antipyretic Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Europe Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 173. Europe Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 174. Europe Anti-inflammatory and Antipyretic Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Europe Anti-inflammatory and Antipyretic Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Europe Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 181. Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 182. Europe Anti-inflammatory and Antipyretic Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Europe Anti-inflammatory and Antipyretic Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Germany Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 185. France Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 186. U.K. Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 187. Italy Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 188. Russia Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 189. Spain Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 191. Switzerland Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 192. Sweden Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 193. Poland Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 194. China Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 195. China Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 196. China Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 197. China Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 198. China Anti-inflammatory and Antipyretic Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 199. China Anti-inflammatory and Antipyretic Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 200. China Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 201. China Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 202. China Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 203. China Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 204. China Anti-inflammatory and Antipyretic Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 205. China Anti-inflammatory and Antipyretic Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 207. Asia Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 208. Asia Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 209. Asia Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 210. Asia Anti-inflammatory and Antipyretic Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 211. Asia Anti-inflammatory and Antipyretic Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 212. Asia Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 213. Asia Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 214. Asia Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 215. Asia Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 216. Asia Anti-inflammatory and Antipyretic Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 217. Asia Anti-inflammatory and Antipyretic Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 218. Asia Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 219. Asia Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 220. Asia Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 221. Asia Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 222. Asia Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 223. Asia Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 224. Asia Anti-inflammatory and Antipyretic Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 225. Asia Anti-inflammatory and Antipyretic Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 226. Japan Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 227. South Korea Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 228. India Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 229. Australia Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 230. Taiwan Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 231. Southeast Asia Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 232. SAMEA Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2026) & (US$ Million) Table 233. SAMEA Anti-inflammatory and Antipyretic Granules Revenue by Type (2027-2032) & (US$ Million) Table 234. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2026) & (K Units) Table 235. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Type (2027-2032) & (K Units) Table 236. SAMEA Anti-inflammatory and Antipyretic Granules Sales Price by Type (2021-2026) & (US$/Unit) Table 237. SAMEA Anti-inflammatory and Antipyretic Granules Sales Price by Type (2027-2032) & (US$/Unit) Table 238. SAMEA Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2026) & (US$ Million) Table 239. SAMEA Anti-inflammatory and Antipyretic Granules Revenue by Application (2027-2032) & (US$ Million) Table 240. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2026) & (K Units) Table 241. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Application (2027-2032) & (K Units) Table 242. SAMEA Anti-inflammatory and Antipyretic Granules Sales Price by Application (2021-2026) & (US$/Unit) Table 243. SAMEA Anti-inflammatory and Antipyretic Granules Sales Price by Application (2027-2032) & (US$/Unit) Table 244. SAMEA Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 245. SAMEA Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 246. SAMEA Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 247. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 248. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Country (2021-2026) & (K Units) Table 249. SAMEA Anti-inflammatory and Antipyretic Granules Sales by Country (2027-2032) & (K Units) Table 250. SAMEA Anti-inflammatory and Antipyretic Granules Sales Price by Country (2021-2026) & (US$/Unit) Table 251. SAMEA Anti-inflammatory and Antipyretic Granules Sales Price by Country (2027-2032) & (US$/Unit) Table 252. Brazil Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 253. Argentina Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 254. Chile Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 255. Colombia Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 256. Peru Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 257. Saudi Arabia Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 258. Israel Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 259. UAE Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 260. Turkey Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 261. Iran Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 262. Egypt Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Table 263. Key Raw Materials Table 264. Raw Materials Key Suppliers Table 265. Anti-inflammatory and Antipyretic Granules Distributors List Table 266. Anti-inflammatory and Antipyretic Granules Customers List Table 267. Research Programs/Design for This Report Table 268. Authors List of This Report Table 269. Secondary Sources Table 270. Primary Sources List of Figures Figure 1. Anti-inflammatory and Antipyretic Granules Image Figure 2. Global Anti-inflammatory and Antipyretic Granules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory and Antipyretic Granules Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pack of 10 Image Figure 5. Pack of 16 Image Figure 6. Global Anti-inflammatory and Antipyretic Granules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Anti-inflammatory and Antipyretic Granules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Online Sales Image Figure 9. Offline Sales Image Figure 10. Global Anti-inflammatory and Antipyretic Granules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Anti-inflammatory and Antipyretic Granules Revenue (2021-2032) & (US$ Million) Figure 12. Global Anti-inflammatory and Antipyretic Granules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021-2032) Figure 15. Global Anti-inflammatory and Antipyretic Granules Sales (2021-2032) & (K Units) Figure 16. Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Anti-inflammatory and Antipyretic Granules Sales YoY (2021-2032) & (K Units) Figure 19. Europe Anti-inflammatory and Antipyretic Granules Sales YoY (2021-2032) & (K Units) Figure 20. China Anti-inflammatory and Antipyretic Granules Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Anti-inflammatory and Antipyretic Granules Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Anti-inflammatory and Antipyretic Granules Sales YoY (2021-2032) & (K Units) Figure 23. Global Anti-inflammatory and Antipyretic Granules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Anti-inflammatory and Antipyretic Granules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2032) Figure 29. Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2032) Figure 32. Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2032) Figure 35. Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2032) Figure 38. North America Anti-inflammatory and Antipyretic Granules Revenue Share by Type (2021-2032) Figure 39. North Amer

Scope & coverage.

Types
  • Pack of 10
  • Pack of 16
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Dong'e Ejiao Co., Ltd.
  • Guangdong Baihe Pharmaceutical Co., Ltd.
  • Guangxi Tiantianle Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hubei Dongxin Pharmaceutical Co., Ltd.
  • Hubei Nordeson Pharmaceutical Co., Ltd.
  • Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  • Liaoning Xingao Pharmaceutical Co., Ltd.
  • Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  • Shaanxi Buchang Pharmaceutical Co., Ltd.
  • Shaanxi Han Tang Pharmaceutical Co., Ltd.
  • Shenyang Junyuan Pharmaceutical Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Yunnan Longfa Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Anti-inflammatory and Antipyretic Granules Market by Type
  3. 1.2.1 Global Anti-inflammatory and Antipyretic Granules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pack of 10
  5. 1.2.3 Pack of 16
  6. 1.3 Anti-inflammatory and Antipyretic Granules Market by Application
  7. 1.3.1 Global Anti-inflammatory and Antipyretic Granules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Online Sales
  9. 1.3.3 Offline Sales
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Anti-inflammatory and Antipyretic Granules Market Dynamics
  1. 2.1 Anti-inflammatory and Antipyretic Granules Industry Trends
  2. 2.2 Anti-inflammatory and Antipyretic Granules Industry Drivers
  3. 2.3 Anti-inflammatory and Antipyretic Granules Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory and Antipyretic Granules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Anti-inflammatory and Antipyretic Granules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Region
  3. 3.2.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2021-2026)
  5. 3.2.3 Global Anti-inflammatory and Antipyretic Granules Revenue by Region (2027-2032)
  6. 3.2.4 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Anti-inflammatory and Antipyretic Granules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Anti-inflammatory and Antipyretic Granules Sales by Region
  9. 3.4.1 Global Anti-inflammatory and Antipyretic Granules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Anti-inflammatory and Antipyretic Granules Sales by Region (2021-2026)
  11. 3.4.3 Global Anti-inflammatory and Antipyretic Granules Sales by Region (2027-2032)
  12. 3.4.4 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Manufacturers
  2. 4.1.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Anti-inflammatory and Antipyretic Granules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Anti-inflammatory and Antipyretic Granules Sales by Manufacturers
  6. 4.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Anti-inflammatory and Antipyretic Granules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Anti-inflammatory and Antipyretic Granules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Anti-inflammatory and Antipyretic Granules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Anti-inflammatory and Antipyretic Granules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Anti-inflammatory and Antipyretic Granules Manufacturers, Product Type & Application
  13. 4.7 Global Anti-inflammatory and Antipyretic Granules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Anti-inflammatory and Antipyretic Granules Market CR5 and HHI
  16. 4.8.2 2025 Anti-inflammatory and Antipyretic Granules Tier 1, Tier 2, and Tier 3
5 Anti-inflammatory and Antipyretic Granules Market by Type
  1. 5.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Type
  2. 5.1.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Anti-inflammatory and Antipyretic Granules Sales by Type
  6. 5.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Type (2021-2032)
  9. 5.3 Global Anti-inflammatory and Antipyretic Granules Price by Type
6 Anti-inflammatory and Antipyretic Granules Market by Application
  1. 6.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Application
  2. 6.1.1 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Anti-inflammatory and Antipyretic Granules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Anti-inflammatory and Antipyretic Granules Sales by Application
  6. 6.2.1 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Anti-inflammatory and Antipyretic Granules Sales Market Share by Application (2021-2032)
  9. 6.3 Global Anti-inflammatory and Antipyretic Granules Price by Application
7 Company Profiles
  1. 7.1 Dong'e Ejiao Co., Ltd.
  2. 7.1.1 Dong'e Ejiao Co., Ltd. Company Information
  3. 7.1.2 Dong'e Ejiao Co., Ltd. Business Overview
  4. 7.1.3 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Dong'e Ejiao Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  6. 7.1.5 Dong'e Ejiao Co., Ltd. Recent Developments
  7. 7.2 Guangdong Baihe Pharmaceutical Co., Ltd.
  8. 7.2.1 Guangdong Baihe Pharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Guangdong Baihe Pharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Guangdong Baihe Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  12. 7.2.5 Guangdong Baihe Pharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Guangxi Tiantianle Pharmaceutical Co., Ltd.
  14. 7.3.1 Guangxi Tiantianle Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Guangxi Tiantianle Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Guangxi Tiantianle Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  18. 7.3.5 Guangxi Tiantianle Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Hebei Tiancheng Pharmaceutical Co., Ltd.
  20. 7.4.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  24. 7.4.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Hubei Dongxin Pharmaceutical Co., Ltd.
  26. 7.5.1 Hubei Dongxin Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Hubei Dongxin Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hubei Dongxin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  30. 7.5.5 Hubei Dongxin Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Hubei Nordeson Pharmaceutical Co., Ltd.
  32. 7.6.1 Hubei Nordeson Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Hubei Nordeson Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hubei Nordeson Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  36. 7.6.5 Hubei Nordeson Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Jilin Xianfeng Technology Pharmaceutical Co., Ltd.
  38. 7.7.1 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Company Information
  39. 7.7.2 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Business Overview
  40. 7.7.3 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  42. 7.7.5 Jilin Xianfeng Technology Pharmaceutical Co., Ltd. Recent Developments
  43. 7.8 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  44. 7.8.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  48. 7.8.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Liaoning Xingao Pharmaceutical Co., Ltd.
  50. 7.9.1 Liaoning Xingao Pharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Liaoning Xingao Pharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Liaoning Xingao Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  54. 7.9.5 Liaoning Xingao Pharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd.
  56. 7.10.1 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Company Information
  57. 7.10.2 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Business Overview
  58. 7.10.3 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  60. 7.10.5 Nanning Kangnuo Biochemical Pharmaceutical Co., Ltd. Recent Developments
  61. 7.11 Shaanxi Buchang Pharmaceutical Co., Ltd.
  62. 7.11.1 Shaanxi Buchang Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Shaanxi Buchang Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shaanxi Buchang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  66. 7.11.5 Shaanxi Buchang Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Shaanxi Han Tang Pharmaceutical Co., Ltd.
  68. 7.12.1 Shaanxi Han Tang Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Shaanxi Han Tang Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Shaanxi Han Tang Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  72. 7.12.5 Shaanxi Han Tang Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Shenyang Junyuan Pharmaceutical Co., Ltd.
  74. 7.13.1 Shenyang Junyuan Pharmaceutical Co., Ltd. Company Information
  75. 7.13.2 Shenyang Junyuan Pharmaceutical Co., Ltd. Business Overview
  76. 7.13.3 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shenyang Junyuan Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  78. 7.13.5 Shenyang Junyuan Pharmaceutical Co., Ltd. Recent Developments
  79. 7.14 Sichuan Kelun Pharmaceutical Co., Ltd.
  80. 7.14.1 Sichuan Kelun Pharmaceutical Co., Ltd. Company Information
  81. 7.14.2 Sichuan Kelun Pharmaceutical Co., Ltd. Business Overview
  82. 7.14.3 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Sichuan Kelun Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  84. 7.14.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments
  85. 7.15 Sichuan Luye Pharmaceutical Co., Ltd.
  86. 7.15.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  87. 7.15.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  88. 7.15.3 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sichuan Luye Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  90. 7.15.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  91. 7.16 Yunnan Baiyao Group Co., Ltd.
  92. 7.16.1 Yunnan Baiyao Group Co., Ltd. Company Information
  93. 7.16.2 Yunnan Baiyao Group Co., Ltd. Business Overview
  94. 7.16.3 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Yunnan Baiyao Group Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  96. 7.16.5 Yunnan Baiyao Group Co., Ltd. Recent Developments
  97. 7.17 Yunnan Longfa Pharmaceutical Co., Ltd.
  98. 7.17.1 Yunnan Longfa Pharmaceutical Co., Ltd. Company Information
  99. 7.17.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
  100. 7.17.3 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Yunnan Longfa Pharmaceutical Co., Ltd. Anti-inflammatory and Antipyretic Granules Product Portfolio
  102. 7.17.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Anti-inflammatory and Antipyretic Granules Market Size by Type
  2. 8.1.1 North America Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  3. 8.1.2 North America Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  4. 8.1.3 North America Anti-inflammatory and Antipyretic Granules Price by Type (2021-2032)
  5. 8.2 North America Anti-inflammatory and Antipyretic Granules Market Size by Application
  6. 8.2.1 North America Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  7. 8.2.2 North America Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  8. 8.2.3 North America Anti-inflammatory and Antipyretic Granules Price by Application (2021-2032)
  9. 8.3 North America Anti-inflammatory and Antipyretic Granules Market Size by Country
  10. 8.3.1 North America Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Anti-inflammatory and Antipyretic Granules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Anti-inflammatory and Antipyretic Granules Market Size by Type
  2. 9.1.1 Europe Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  3. 9.1.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  4. 9.1.3 Europe Anti-inflammatory and Antipyretic Granules Price by Type (2021-2032)
  5. 9.2 Europe Anti-inflammatory and Antipyretic Granules Market Size by Application
  6. 9.2.1 Europe Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  7. 9.2.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  8. 9.2.3 Europe Anti-inflammatory and Antipyretic Granules Price by Application (2021-2032)
  9. 9.3 Europe Anti-inflammatory and Antipyretic Granules Market Size by Country
  10. 9.3.1 Europe Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Anti-inflammatory and Antipyretic Granules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Anti-inflammatory and Antipyretic Granules Market Size by Type
  2. 10.1.1 China Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  3. 10.1.2 China Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  4. 10.1.3 China Anti-inflammatory and Antipyretic Granules Price by Type (2021-2032)
  5. 10.2 China Anti-inflammatory and Antipyretic Granules Market Size by Application
  6. 10.2.1 China Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  7. 10.2.2 China Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  8. 10.2.3 China Anti-inflammatory and Antipyretic Granules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Anti-inflammatory and Antipyretic Granules Market Size by Type
  2. 11.1.1 Asia Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  3. 11.1.2 Asia Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  4. 11.1.3 Asia Anti-inflammatory and Antipyretic Granules Price by Type (2021-2032)
  5. 11.2 Asia Anti-inflammatory and Antipyretic Granules Market Size by Application
  6. 11.2.1 Asia Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  7. 11.2.2 Asia Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  8. 11.2.3 Asia Anti-inflammatory and Antipyretic Granules Price by Application (2021-2032)
  9. 11.3 Asia Anti-inflammatory and Antipyretic Granules Market Size by Country
  10. 11.3.1 Asia Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Anti-inflammatory and Antipyretic Granules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Anti-inflammatory and Antipyretic Granules Market Size by Type
  2. 12.1.1 SAMEA Anti-inflammatory and Antipyretic Granules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Anti-inflammatory and Antipyretic Granules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Anti-inflammatory and Antipyretic Granules Price by Type (2021-2032)
  5. 12.2 SAMEA Anti-inflammatory and Antipyretic Granules Market Size by Application
  6. 12.2.1 SAMEA Anti-inflammatory and Antipyretic Granules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Anti-inflammatory and Antipyretic Granules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Anti-inflammatory and Antipyretic Granules Price by Application (2021-2032)
  9. 12.3 SAMEA Anti-inflammatory and Antipyretic Granules Market Size by Country
  10. 12.3.1 SAMEA Anti-inflammatory and Antipyretic Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Anti-inflammatory and Antipyretic Granules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Anti-inflammatory and Antipyretic Granules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Anti-inflammatory and Antipyretic Granules Value Chain Analysis
  2. 13.1.1 Anti-inflammatory and Antipyretic Granules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Anti-inflammatory and Antipyretic Granules Production Mode & Process
  6. 13.2 Anti-inflammatory and Antipyretic Granules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Anti-inflammatory and Antipyretic Granules Distributors
  9. 13.2.3 Anti-inflammatory and Antipyretic Granules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst